MetLife (MET) Tops Q3 EPS by 21c

MetLife (NYSE: MET) reported Q3 EPS of $1.60, $0.21 better than the analyst estimate of $1.39.

Third quarter 2014 operating earnings included the following items:

• variable investment income above the company’s 2014 quarterly plan range by $62 million, or $0.05 per share, after tax and the impact of deferred policy acquisition costs (DAC)
• favorable catastrophe experience and prior year development, which increased operating earnings by $38 million relative to plan, or $0.03 per share, after tax
• a favorable one-time tax adjustment related to the filing of the company’s U.S. federal tax return, which increased operating earnings by $32 million, or $0.03 per share, after tax
• results of the annual actuarial assumption review, which increased operating earnings by $16 million, or $0.01 per share, after tax
• the impact of Chilean tax reform, which decreased operating earnings by $41 million, or $0.04 per share, after tax

MetLife’s operating return on equity, excluding accumulated other comprehensive income (AOCI), other than foreign currency translation adjustments (FCTA) (ROE)* was 13.2 percent for the third quarter and the company’s tangible operating ROE* was 16.7 percent.

For earnings history and earnings-related data on MetLife (MET) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
• Brookfield Renewable Energy Partners (BEP) Misses Q3 EPS by 15c
• Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance